Are you a startup or university-based project pioneering the future of therapeutics and vaccines? BARDA is looking for innovative solutions that align with its mission to enhance pandemic preparedness and health security. Apply to the VITAL Biotech Accelerator & Funding Award Programs and make a global impact!
VITAL (Vaccine Innovation and Therapeutics Acceleration Launchpad) is a BARDA Accelerator Network (BAN) Hub supporting the development and acceleration of next-generation therapeutic and vaccine platforms and technologies to promote health security. VITAL is led by Start2 Group in collaboration with partners Advise Connect Inspire (ACI) and BioLabs.
On the one hand, there is the opportunity to participate in a specially designed Biotech Accelerator and additionally receive non-dilutive funding in the amount of USD 50k to USD 200k.
Application deadline: August 23, 2024.
Further information can be found at: VITAL Biotech Accelerator Program and VITAL Non-Dilutive Funding.